Global Prostate Cancer Treatment Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and Forecasts, 2017 to 2025

  • ID: 4431619
  • Report
  • Region: Global
  • Acute Market Reports
1 of 4

FEATURED COMPANIES

  • Abbott Laboratories
  • Astellas Pharma, Inc.
  • AstraZeneca Plc
  • Ferring Pharmaceuticals
  • Ipsen
  • Johnson & Johnson
  • MORE
Prostate Cancer Treatment Market - Market Growth, Future Prospects, Competitive Analysis and Pipeline Analysis, 2017 - 2025, the prostate cancer treatment market was valued at US$5.63 Bn in 2016, and is expected to reach US$ 18.4 Bn by 2025 expanding at a CAGR of 12.3% from 2017 to 2025.

Market Insights

The key risk factors for prostate cancer development is being old age, genetic, obesity and race. Around 99% of the cases for prostate cancer is most commonly seen after the age of 50 years. The currently available treatment are biological therapy and chemotherapy. Biological therapy are considered as the largest segment of prostate cancer treatment market as it is the preferred first line of treatment. Chemotherapy is an option to the patients who are resistant to the Biological therapy. The key factors assisting the growth of prostate cancer treatment market are growing prevalence of prostate cancer coupled with growing public awareness, rising healthcare expenditure in the developed and developing regions and developing technology of pharmaceutical companies leading to more target specific drugs with lesser side effects and strong emerging pipeline. On the other hand, insufficient funding in developing and under developed countries and high cost involved in the treatment of the disease are hindering the market growth of prostate cancer treatment.

Pipeline Analysis

Pipeline of prostate cancer treatment market is dense and comprises combination of biological drugs and chemotherapy drugs. However, the no. of biological therapy molecules is more in the phase III of clinical trials compared to chemotherapy. We have estimated sales of very specific molecules based on the type (biological or chemical), disease prevalence, sponsor, depicted peak sales by leading market experts and other factors.

Key Market Movements:
  • Rising prevalence of prostate cancer in developed and developing countries
  • Aging population, in developed countries is expected to boost the market
  • Government and non-government initiatives to fight prostate cancer and supporting reimbursement policies
  • Rising public awareness with early disease diagnosis and strong emerging pipeline is expected to boost the Prostate cancer treatment market
READ MORE
Note: Product cover images may vary from those shown
2 of 4

FEATURED COMPANIES

  • Abbott Laboratories
  • Astellas Pharma, Inc.
  • AstraZeneca Plc
  • Ferring Pharmaceuticals
  • Ipsen
  • Johnson & Johnson
  • MORE
Chapter 1 Preface
1.1 Report Description
1.1.1 Purpose of the Report
1.1.2 Target Audience
1.1.3 USP and Key Offerings
1.2 Research Scope
1.3 Research Methodology
1.3.1 Phase I - Secondary Research
1.3.2 Phase II - Primary Research
1.3.3 Phase III - Expert Panel Review
1.3.4 Assumptions

Chapter 2 Executive Summary
2.1 Global Prostate Cancer Treatment Market Portraiture
2.2 Global Prostate Cancer Treatment Market, by Type of Treatment, 2016 (US$ Mn)
2.3 Global Prostate Cancer Treatment Market Share, by Geography, 2016 (Value %)

Chapter 3 Prostate Cancer Treatment Market Analysis
3.1 Global Prostate Cancer Treatment Market Overview
3.2 Market Dynamics
3.2.1 Market Drivers
3.2.1.1 Growing Prevalence of Prostate Cancer
3.2.1.2 Rise in aging population and public awareness of Prostate cancer
3.2.2 Challenges
3.2.2.1 Ambiguous Reimbursement Policies causing decrease in healthcare expenditure
3.2.3 Opportunities
3.2.3.1 Developing R&D technology leading to more target specific drugs and strong emerging pipeline
3.3 Attractive Investment Proposition
3.4 Competitive Landscape of Key Players in Prostate Cancer Treatment Market

Chapter 4 Global Prostate Cancer Treatment Market Analysis, by Treatment
4.1 Introduction
4.2 Biological Therapy
4.2.1 Enzalutamid
4.2.2 Abiraterone
4.2.3 Leuprolide
4.2.4 Goserelin
4.2.5 Triptorelin
4.2.6 Histrelin
4.2.7 Degarelix
4.2.8 Sipuleucel-T
4.3 Chemotherapy
4.3.1 Mitotic inhibitors e.g. Docetaxel, Cabazitaxel
4.3.2 Topoisomerase inhibitors e.g. Mitoxantrone
4.3.3 Alkylating antineoplastic agent e.g. Estramustine

Chapter 5 Global Prostate Cancer Treatment Market, By Geography
5.1 Preface
5.2 North America (U.S. & Canada)
5.3 Europe (U.K., Germany & Rest of Europe)
5.4 Asia Pacific (China, Japan and Rest of APAC)
5.5 Latin America (Brazil, Mexico and Rest of Latin America)
5.6 Middle East and Africa (United Arab Emirates, Saudi Arabia and Rest of Middle East and Africa)

Chapter 6 Company Profiles
6.1 Tolmar Inc.
6.2 Astellas Pharma, Inc.
6.3 AstraZeneca Plc
6.4 Ferring Pharmaceuticals
6.5 Johnson & Johnson
6.6 Abbott Laboratories
6.7 Sanofi
6.8 Ipsen
6.9 Novartis
6.10 Bayer Healthcare Pharmaceuticals, Inc

List of Figures
Fig. 1 Prostate Cancer Treatment Market: Research Methodology
Fig. 2 Global Prostate Cancer Treatment Market, by Type of Treatment, 2016 (US$ Mn)
Fig. 3 Global Prostate Cancer Treatment Market Share, by Geography, 2016 (Value %)
Fig. 4 Attractive Investment Proposition: Global Prostate Cancer Treatment Market, by Geography
Fig. 5 Enzalutamid Market for Prostate Cancer treatment, 2015 - 2025 (US$ Mn)
Fig. 6 Abiraterone Market for Prostate Cancer treatment, 2015 - 2025 (US$ Mn)
Fig. 7 Leuprolide Market for Prostate Cancer treatment, 2015 - 2025 (US$ Mn)
Fig. 8 Goserelin Market for Prostate Cancer treatment, 2015 - 2025 (US$ Mn)
Fig. 9 Triptorelin Market for Prostate Cancer treatment, 2015 - 2025 (US$ Mn)
Fig. 10 Histrelin Market for Prostate Cancer treatment, 2015 - 2025 (US$ Mn)
Fig. 11 Degarelix Market for Prostate Cancer treatment, 2015 - 2025 (US$ Mn)
Fig. 12 Sipuleucel-T Market for Prostate Cancer treatment, 2015 - 2025 (US$ Mn)
Fig. 13 Mitotic inhibitors Market for Prostate Cancer treatment, 2015 - 2025 (US$ Mn)
Fig. 14 Topoisomerase inhibitors Market for Prostate Cancer treatment, 2015 - 2025 (US$ Mn)
Fig. 15 Alkylating antineoplastic agent Market for Prostate Cancer treatment, 2015 - 2025 (US$ Mn)
Fig. 16 North America Prostate Cancer Treatment Market,2015 - 2025 (US$ Mn)
Fig. 17 Europe Prostate Cancer Treatment Market, 2015 - 2025 (US$ Mn)
Fig. 18 Asia Pacific Prostate Cancer Treatment Market, 2015 - 2025 (US$ Mn)
Fig. 19 Latin America Prostate Cancer Treatment Market, 2015 - 2025 (US$ Mn)
Fig. 20 Middle East and Africa Prostate Cancer Treatment Market, 2015 - 2025 (US$ Mn)

List of Tables
Table 1 Market Positioning of Key Players in Global Prostate Cancer Treatment Market
Table 2 Global Prostate Cancer Treatment Market, by Treatment, 2015 - 2025 (US$ Mn)
Table 3 Global Prostate Cancer Treatment Market, Biological Therapy, 2015 - 2025 (US$ Mn)
Table 4 Global Prostate Cancer Treatment Market, Chemotherapy, 2015 - 2025 (US$ Mn)
Table 5 Global Prostate Cancer Treatment Market, by Geography, 2015 - 2025 (US$ Mn)
Table 6 Tolmar Inc.: Company Snapshot (Business Description; Financial Information; Product Position/Portfolio; News Coverage)
Table 7 Astellas Pharma, Inc.: Company Snapshot (Business Description; Financial Information; Product Position/Portfolio; News Coverage)
Table 8 AstraZeneca Plc.: Company Snapshot (Business Description; Financial Information; Product Position/Portfolio; News Coverage)
Table 9 Ferring Pharmaceuticals: Company Snapshot (Business Description; Financial Information; Product Position/Portfolio; News Coverage)
Table 10 Johnson & Johnson: Company Snapshot (Business Description; Financial Information; Product Position/Portfolio; News Coverage)
Table 11 Abbott Laboratories: Company Snapshot (Business Description; Financial Information; Product Position/Portfolio; News Coverage)
Table 12 Sanofi: Company Snapshot (Business Description; Financial Information; Product Position/Portfolio; News Coverage)
Table 13 Ipsen: Company Snapshot (Business Description; Financial Information; Product Position/Portfolio; News Coverage)
Table 14 Novartis: Company Snapshot (Business Description; Financial Information; Product Position/Portfolio; News Coverage)
Table 15 Bayer Healthcare Pharmaceuticals, Inc.: Company Snapshot (Business Description; Financial Information; Product Position/Portfolio; News Coverage)
Note: Product cover images may vary from those shown
3 of 4

Loading
LOADING...

4 of 4
  • Tolmar Inc.
  • Astellas Pharma, Inc.
  • AstraZeneca Plc
  • Ferring Pharmaceuticals
  • Johnson & Johnson
  • Abbott Laboratories
  • Sanofi
  • Ipsen
  • Novartis
  • Bayer Healthcare Pharmaceuticals, Inc
Note: Product cover images may vary from those shown
5 of 4
Note: Product cover images may vary from those shown
Adroll
adroll